Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

The Clinical Trial Vanguard
clinicaltrialvanguard.com > news > nektar-to-release-24-week-off-treatment-data-for-rezpegaldesleukin-in-alopecia-areata

Nektar to Release 24-Week Off-Treatment Data for Rezpegaldesleukin in Alopecia Areata

3+ day, 18+ hour ago   (323+ words) The Clinical Trial Vanguard Nektar to Release 24-Week Off-Treatment Data for Rezpegaldesleukin in Alopecia Areata Nektar Therapeutics went quiet on September 8, 2026, and will stay that way until it releases the 24-week off-treatment follow-up data from its Phase 2b REZOLVE-AA study of…...